Skip to main content
SpringerLink
Log in

A Review of the Therapy of Paraneoplastic Neurologic Syndromes

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The therapy of paraneoplastic neurologic syndromes remains unclear and warrants a systematic review of the literature. Reports in English and foreign language literature were abstracted. Data were sorted by the primary paraneoplastic neurologic syndrome, the primary malignancy, and the methods of treatment. Neurologic improvement follows surgical, chemotherapeutic, and radiation treatments. Adjuvant immunosuppressive therapy with steroids, plasmapheresis, or immunoglobulin may help stabilize the progression of neurologic symptoms. Syndromes characterized by inflammation or neurotransmitter production without neuronal loss are most responsive to therapy. While treatment of the underlying cancer with appropriate surgery, chemotherapy, and radiation is recommended, the paraneoplastic syndrome should probably be managed with immunosuppressive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berglund S, Eriksson M, von Eyben FE, Hellekant C, Mattsson W: Remission by chemotherapy of the Eaton-Lambert myasthenic syndrome in a patient with small cell bronchogenic carcinoma. Acta Med Scand 212: 429-432, 1982

    PubMed  Google Scholar 

  2. Brennan LV, Cradock PR: Limbic encephalopathy as a nonmetastatic complication of oat cell lung cancer: its reversal after treatment of the primary lung lesion. Am J Med 75: 518-520, 1983

    PubMed  Google Scholar 

  3. Cher L, Hochberg FH, Teruya J et al.: Therapy of paraneoplastic syndromes in six patients with Protein A column immunadsorption. Cancer 75: 1677-1683, 1995.

    Google Scholar 

  4. Cocconi G, Ceci G, Juvarra G, Minopoli MR, Cocchi T, Fiaccadori F, Lechi A, Boni P: Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 56: 2318-2320, 1985

    PubMed  Google Scholar 

  5. Dalmau J, Posner JB: Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurol 44: 2241-2246, 1994

    Google Scholar 

  6. Schold SC, Cho ES, Somasundaram M, Posner JB: Subacute motor neuronopathy: a remote effect of lymphoma. Annals Neurol 5: 271-287, 1979

    Google Scholar 

  7. Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB: A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurol 38: 1018-1025; 1988

    Google Scholar 

  8. Cairncross JG, Posner JB: Neurological complications of malignant lymphoma. Handbook of Clinical Neurology, Vinken and Bruyn, New York, 1980, part 39 pp 55

    Google Scholar 

  9. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA: Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 65: 1423-1431, 1990

    PubMed  Google Scholar 

  10. Furman JMR, Eidelman BH, Fromm GH: Spontaneous remission of paraneoplastic ocular flutter and saccadic intrusions. Neurology 38: 499-501, 1988

    PubMed  Google Scholar 

  11. Ridley A, Kennard C, Scholtz CL, Büttner-Ennever SA, Summers B, Turnball A: Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110: 1699-1709, 1987

    PubMed  Google Scholar 

  12. Luque FA, Furneaux HM, Ferziger R et al.: Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Annals Neurol 29: 241-251, 1991

    Google Scholar 

  13. Auth TL, Chodoff P: Transient cerebellar syndrome from extracerebral carcinoma. Neurol 7: 370-372, 1957

    Google Scholar 

  14. Kearsley JH, Johnson P, Halmagyi GM: Paraneoplastic cerebellar disease Remission with excision of the primary tumor. Arch Neurol 42: 1208-1210, 1985

    PubMed  Google Scholar 

  15. Paone JP, Jeyasingham K: Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. New England J Medicine 302: 156, 1980

    Google Scholar 

  16. Enevoldson TP, Ball JA, McGregor JM: Resolution of a severe sensorimotor neuropathy following the resection of an associated asymptomatic gastric lymphoma. J Neurol Neurosurg Psych 53: 267-268, 1990

    Google Scholar 

  17. Fawcett DP, McBrien MP: Transitional cell carcinoma of the renal pelvis presenting with peripheral neuropathy. Brit J Urol 49: 202, 1977

    PubMed  Google Scholar 

  18. Stephens TW, Rousgas A, Ghose MK: Pure motor neuropathy complicating carcinoma of bronchus removed after surgery. Brit J Diseas Chest 60: 107-109, 1966

    Google Scholar 

  19. Evans BK, Fagan C, Arnold T, Dropcho EJ, Oh SJ: Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurol 40: 960-962, 1990

    Google Scholar 

  20. Smith B: Skeletal muscle necrosis associated with carcinoma. J Pathol 97: 207-289, 1969

    PubMed  Google Scholar 

  21. Lowe BA, Mershon C, Mangalik A: Paraneoplastic neurologic syndrome in transitional cell carcinoma of the bladder. J Urol 147(2): 462-464, 1992

    PubMed  Google Scholar 

  22. Berg BO, Ablin AR, WangW, Skoglund R: Encephalopathy associated with occult neuroblastoma. J Neurosurg 41: 567-572, 1974

    PubMed  Google Scholar 

  23. Davidson M, Tolentino, Sapir S: Opsoclonus and neuroblastoma. New England J Medicine 279: 948, 1968

    Google Scholar 

  24. Dyken P, Kolar O: Dancing eyes, dancing feet: infantile polymyoclonia. Brain 91: 305-320, 1968

    PubMed  Google Scholar 

  25. Solomon GE, Chutorian AM: Opsoclonus and occult neuroblastoma. New England J Medicine 279: 475-477, 1968

    Google Scholar 

  26. Chalk CH, Murray NMF, Newsom-Davis J, O'Neill JH, Spiro SG: Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small cell lung cancer. Neurol 40: 1552-1556, 1990

    Google Scholar 

  27. Clamon GH, Evans WK, Shepherd FA, Humphrey JG: Myasthenic syndrome and small cell cancer of the lung: variable response to antineoplastic therapy. Arch Internal Medicine 144: 999-1000, 1984

    Google Scholar 

  28. Park DM, Johnson RH, Crean GP, Robinson JF: Orthostatic hypotension in bronchial carcinoma. Brit Med J 3: 510-511, 1972

    PubMed  Google Scholar 

  29. Jablecki C: Lambert-Eaton myasthenic syndrome. Muscle Nerve 7: 250-257, 1984

    PubMed  Google Scholar 

  30. Jenkyn LR, Brooks PL, Forcier RJ, Maurer LH, Ochoa J: Remission of the Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy. Cancer 46: 1123-1127, 1980

    PubMed  Google Scholar 

  31. Kalter S, Dhingra HM, Farha P: Primary therapy for small cell lung cancer reversing the Eaton-Lambert syndrome. South Med J 78: 197-198, 1985

    PubMed  Google Scholar 

  32. Oh SJ: SFEMG improvement with remission in the cancer associated Lambert-Eaton myasthenic syndrome. Muscle Nerve 12: 844-848, 1989

    PubMed  Google Scholar 

  33. Markham M, Abeloff MD: Small cell lung cancer and limbic encephalitis. Ann Internal Med 96: 785, 1982

    Google Scholar 

  34. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB: Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurol 38: 1391-1398, 1988

    Google Scholar 

  35. Anderson NE, Budde-Steffen C, RosenblumMet al.: Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine 67: 100-109, 1988

    PubMed  Google Scholar 

  36. Ferrari P, Federico M, Grimaldi LME, Silingardi V: Stiffman syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome. Haematologica 75: 570-572, 1990

    PubMed  Google Scholar 

  37. Khandekar JD, Oyer D, Miller HJ, Vick NA: Neurologic involvement in glucagonoma syndrome. Response to combination chemotherapy with 5-fluorouracil and streptozotocin. Cancer 44: 2014-2016, 1979

    PubMed  Google Scholar 

  38. Lambrecht ER, van der Loos TLJM, van der Eerden AHAM: Retrobulbar neuritis as the first sign of glucagonoma syndrome. Internat Ophthalmol 11: 13-15, 1987

    Google Scholar 

  39. Dalmau J, Graus F, Rosenblum MK, Posner JB: Anti-Huassociated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 71: 59-72, 1992

    PubMed  Google Scholar 

  40. Ingram PA, Davis GR, Schwartz MS, Traub M, Newland AC, Swash M: Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment. J Neurol, Neurosurg Psych 47: 806-812, 1984

    Google Scholar 

  41. Sapra R, Armentrout S, Margileth D, Opfell R: Subacute cerebellar degeneration in Hodgkin's disease (HD): successful treatment with plasmapheresis. Proc Am Ass Canc Res 22: 511, 1981

    Google Scholar 

  42. Fisher PG, Wechsler DS, Singer HS: Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Ped Neurol 10: 309-312, 1994

    Google Scholar 

  43. Case Records of the Massachusetts General Hospital. (Case 9-1988) New England J Medicine 318: 563-570, 1988

    Google Scholar 

  44. Herishanu Y: Immunological abnormalities in opsoclonus cerebellopathy. Neuro-Ophthalmol 5: 271-275, 1985

    Google Scholar 

  45. Nausieda PA, Tanner CM, Weiner WJ: Opsoclonic cerebellopathy. A paraneoplastic syndrome responsive to thiamine. Arch Neurol 38: 780-781, 1981

    PubMed  Google Scholar 

  46. Masson C, Prier S, Benoit C, Henin D, Masson M, Cambier J: Amnesia and Stiffman syndrome. Manifestations disclosing paraneoplastic encephalomyelitis. Anal Medecine Intern 138: 502-505, 1987

    Google Scholar 

  47. Folli F, Solimena M, Cofiell R, Austoni M, Tallini G, Fasetta G, Bates D, Cartlidge N et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. New England J Medicine 328: 546-551, 1993

    Google Scholar 

  48. Stoll DB, Lublin F, Brodovsky H, Laucius F, Petchefsky A, Cooper H: Association of subacute motor neuronopathy with thymoma. Cancer 54: 770-772, 1984

    PubMed  Google Scholar 

  49. Roobal TH, Kazzaz BA, Vecht CJ: Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome. J Neuro Neurosurg Psych 50: 628-631, 1987

    Google Scholar 

  50. McEvoy KM, Windebank AJ, Daube JR, Low PA: 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. NewEngland J Medicine 321: 1567-1571, 1989

    Google Scholar 

  51. Vincent D, Dubas F, Hauw JJ, Godeau P, Lhermitte F, Buge A, Castaigne P: Nerve and muscle microvasculitis in peripheral neuropathy: a remote effect of cancer? J Neurol Neurosurg Psych 49: 1007-1010, 1986

    Google Scholar 

  52. Oh SJ, Dropcho EJ: Steroid-responsive paraneoplastic encephaloneuropathy. Neurol 40(suppl 1): 246, 1990

    Google Scholar 

  53. Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB: A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurol 38: 1018-1025, 1988

    Google Scholar 

  54. Horwich MS, Cho L, Porro RS, Posner, JB: Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2: 7-19, 1977

    PubMed  Google Scholar 

  55. Victor M, Ferrendelli JA: The nutritional and metabolic diseases of the cerebellum. Clinical and pathological aspects. In: Fields WS, Willis WD Jr., Eds. The cerebellum in health and disease, Chapter 16. St. Louis: Warren H. Green, Inc., 1970: 412-449

    Google Scholar 

  56. Lachance DH, O'Neill BP, Harper CM, Banks PM, Cascino TL: Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease. Mayo Clinic Proceedings 66: 97-101, 1991

    PubMed  Google Scholar 

  57. Torvik A, Berntzen AE: Necrotizing vasculitis without visceral involvement. Post-mortem examination of three cases of affection of skeletal muscles and peripheral nerves. Acta Med Scand 184: 69-77, 1968

    PubMed  Google Scholar 

  58. Oh SJ, Slaughter R, Harrell L: Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscl Nerve1 4: 152-156, 1991

    Google Scholar 

  59. Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D, Tolosa E: Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurol 42(3Pt1): 536-540, 1992

    Google Scholar 

  60. Vega F, Graus F, Chen QM, Schüller E, Poisson M, Delattre JY: Intravenous (iv) immunoglobulin therapy in paraneoplastic neurologic syndromes (pns) with antineuronal antibodies. Neurol 44(suppl 2): 157, 1994

    Google Scholar 

  61. Horwich MS, Cho L, Porro RS, Posner, JB: Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2: 7-19, 1977

    PubMed  Google Scholar 

  62. Sagar HJ, Read DJ: Subacute sensory neuropathy with remission: an association with lymphoma. J Neurol Neurosurg Psych 45: 83-85, 1982

    Google Scholar 

  63. Ambler Z, Janda J: Subacute cerebral atrophy in Hodgkin's disease. Cs Neurol Neurochir 46/79: 36-40, 1983

    Google Scholar 

  64. Mitchell WG, Snodgrass SR: Chronic relapsing steroidsensitive ataxic syndrome in children with ganglioneuroblastoma. Ann Neurol 24: 352, 1988

    Google Scholar 

  65. Peterson K, Rosenblum MK, Kotanides H, Posner JB: Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurol 42: 1931-1937, 1992

    Google Scholar 

  66. Tsukamoto T, Yamamoto H, Iwasaki Y, Yoshie O, Terunuma H, Suzuki H: Antineural antibodies in patients with paraneoplastic cerebellar degeneration. Arch Neurol 46: 1225-1229, 1989

    PubMed  Google Scholar 

  67. Froissart M, Mizon JP, Morcamp D, Demay JP. Atrophie cérébelleuse subaiguë paranéoplasique au cours d'une maladie de Hodgkin. Nouv Presse Med 323: 660-661, 1976

    Google Scholar 

  68. Gonzalez del Val R, Garcia Arroyo R, Villaneueva JA, Moro E: Subacute paraneoplastic cerebellar degeneration in microcytic carcinoma of the lung. Presentation of two cases. Medicine Clinica 99: 701-704, 1992

    Google Scholar 

  69. Greenlee JE, Lipton HL: Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Ann Neurol 19: 82-85, 1986

    PubMed  Google Scholar 

  70. Mintz BJ, Sirota DK: A case report of neurologic improvement following treatment of paraneoplastic cerebellar degeneration. Mt Sinai J Med 60: 163-164, 1993

    PubMed  Google Scholar 

  71. Rewcastle NB: Subacute cerebellar degeneration with Hodgkin's disease. Arch Neurol 9: 407-413, 1963

    Google Scholar 

  72. Greenberg HS: Paraneoplastic cerebellar degeneration: a clinical and CT study. J Neuro-Oncol 2: 377-382, 1984

    Google Scholar 

  73. Royal W, Galasko DR, McKhann GM, Cunningham JM, Dropcho EJ: Clinical course, immunologic, and biochemical features of a patient with paraneoplastic cerebellar degeneration. Neurol 37(suppl 1): 305, 1987

    Google Scholar 

  74. Tsukamoto T, Yoshie O, Tada K, Iwasaki Y: Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration. Arch Neurol 111: 833-837, 1987

    Google Scholar 

  75. Counsell CE, McLeod M, Grant R: Reversal of subacute paraneoplastic cerebellar degeneration with intravenous immunoglobulin. Neurol 44: 1184-1185, 1994

    Google Scholar 

  76. Felician O, Renard JL, Vega F, Créange A, ChenQM, Bequet B, Delattre JY: Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man. Neurol 45: 1226-1227, 1995

    Google Scholar 

  77. Moll JW, Henzen-Logmans SC, van der Meché FGA, Vecht CHJ: Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psych 56: 112-115, 1993

    Google Scholar 

  78. Roberts HJV: A case of spino-cerebellar degeneration associated with carcinoma of the prostate. Med J Australia 1: 391-393, 1967

    PubMed  Google Scholar 

  79. Keltner JL, Roth AM, Chang RS: Photoreceptor degeneration. A possible autoimmune disorder. Arch Ophthalmol 101: 564-569, 1983

    PubMed  Google Scholar 

  80. Klingele TG, Burde RM, Rappazzo JA, Isserman MJ, Burgess D, Kantor O: Paraneoplastic retinopathy. J Clin Neuro-Ophthalmol 4: 239-245, 1984

    Google Scholar 

  81. Jacobson DM, Thirkill CE, Tipping SJ: A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28: 162-167, 1991

    Google Scholar 

  82. Keltner JL, Thirkill CE, Tyler NK, Roth AM: Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110: 48-53, 1992

    PubMed  Google Scholar 

  83. Kilgo GR, Schwartz GM: Opsoclonus: J Clin Neuro-Ophthalmol 4: 109-119, 1984

    Google Scholar 

  84. Lago A, Burguera JA, Vilchez JJ et al. Opsoclonic cerebellar disease. A paraneoplastic syndrome sensitive to chloromethiazole. Anal Medicine Interna 6: 260-262, 1992

    Google Scholar 

  85. Norris FH Jr, Engele WK: Carcinomatous amyotrophic lateral sclerosis. In: Brain WR, Norris FH Jr, eds. The remote effects of cancer on the nervous system. New York: Grune & Stratton, 1965: 24-41

    Google Scholar 

  86. Peters HA, Clatanoff DV: Spinal muscular atrophy secondary to macroglobulinemia. Neurol 18: 101-108, 1968

    Google Scholar 

  87. Sheinman BD, Gawler J: Opsoclonus and polymyoclonia complicating oat-cell carcinoma of the bronchus. Postgrad Med J 58: 704-705, 1982

    PubMed  Google Scholar 

  88. McLoughlin J, Gingell JC, Harper G et al. Cerebellar manifestations of prostatic carcinoma. Postgrad Med J 86: 584-586, 1992

    Google Scholar 

  89. Reddy RV, Vakili ST: Midbrain encephalitis as a remote effect of a malignant neoplasm. Arch Neurol 38: 781-782, 1981

    PubMed  Google Scholar 

  90. Glantz MJ, Biran H, Myers ME et al. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73: 168-175, 1994

    PubMed  Google Scholar 

  91. Escudero D, Barnadas A, Codina M, et al. Anti-Ri associated paraneoplastic neurologic disease without opsoclonus in a patient with breast cancer. Neurol 43: 1605-1606, 1993

    Google Scholar 

  92. Piccolo G, Cosi V: Stiff-man syndrome, dysimmune disorder, and cancer. Ann Neurol 26: 105, 1989

    Google Scholar 

  93. Eekhoff JL: Remission of a paraneoplastic cerebellar degeneration. Clin Neurol Neurosurg 87: 133-134, 1985

    PubMed  Google Scholar 

  94. Vollmer J, Ferbert A, Thron A: Paraneoplastic limbic encephalitis. A case report. Nervenarzt 64: 659-662, 1993

    PubMed  Google Scholar 

  95. Croft PB, Wilkinson M: The course and prognosis in some types of carcinomatousneuromyopathy. Brain 92: 1-8, 1969

    PubMed  Google Scholar 

  96. Leger JM, Bachoud-Levi AC, Eymard B et al. Syndrome myasthenique paranéoplasique. Revue Neurol 149: 485-488, 1993

    Google Scholar 

  97. Brain L, Croft PB, Wilkinson M: Motor neurone disease as a manifestation of neoplasm. Brain 88: 479-500, 1965

    PubMed  Google Scholar 

  98. Bruyland M, Van Belle S, Schallier D et al. Good response of a paraneoplastic neuromyopathy to cyclophosphamide. Cancer Treat Rep 68: 787-789, 1984

    PubMed  Google Scholar 

  99. Johnson PC, Rolak LA, Hamilton RH et al. Paraneoplastic vasculitis of nerve: a remote effect of cancer. Ann Neurol 5: 437-444, 1979

    PubMed  Google Scholar 

  100. Takigawa N, Ohnoshi T, Ueoke H et al. A case of small cell bronchogenic carcinoma accompanied by polyneuropathy and SIADH. Jap J Thoracic Dis 31: 346-351, 1993

    Google Scholar 

  101. Twijnstra A, Verschuuren J, Byrne TN et al. Prolonged or remitting anti-Hu associated paraneoplastic sensory neuronopathy (PSN) and encephalomyelitis (PEM). Neurol 45: A321, 1995

    Google Scholar 

  102. Dodgson MCH, Hoffman HL: Sensory neuropathy associated with carcinoma of the esophagus: report of a case. Ann Internal Med 38: 130-135, 1953

    Google Scholar 

  103. Jaeckle KA, Graus F, Houghton AN et al.: Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 18: 592-600, 1985

    PubMed  Google Scholar 

  104. Younger DS, Rowland LP, Latov N et al. Lymphoma, motor neuron diseases and amyotrophic lateral sclerosis. Ann Neurol 29: 78-86, 1991

    PubMed  Google Scholar 

  105. Toupet M, deGramont A, BacriDet al. Le flutter-opsoclonie. Revue Neurol 138: 219-239, 1982

    Google Scholar 

  106. Carr I: The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1: 844-845, 1982

    PubMed  Google Scholar 

  107. Brownell B, Oppenheimer DR, Hughes JT: The central nervous system in motor neurone disease. JNNP 30: 338-357, 1970

    Google Scholar 

  108. Farrelly C, Daneman A, Chan HS et al. Occult neuroblastoma presenting with opsomyoclonus: utility of computed tomography. AJR 142: 807-810, 1984

    PubMed  Google Scholar 

  109. Hetzel DJ, Stanhope CR, O'Neill BP et al. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clinic Proc 65: 1558-1563, 1990

    Google Scholar 

  110. Alanis BF, Flanagan JF: Myopathy and hypercalcemia occurring with carcinoma of the kidney. JAMA 171: 2076-2080, 1959

    PubMed  Google Scholar 

  111. Croft PB, Urich H, Wilkinson M: Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 90: 31-66, 1967

    PubMed  Google Scholar 

  112. Dropcho EJ, Payne R: Paraneoplastic opsoclonusmyoclonus associated with medullary thyroid cancer and review of the literature. Arch Neurol 43: 410-415, 1986

    PubMed  Google Scholar 

  113. Ahern GL, O'Connor M, Dalmau J et al. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurol 44: 1270-1274, 1994

    Google Scholar 

  114. Ahmed MN, Carpenter S: Autonomic neuropathy and carcinoma of the lung. Canadian Med Ass J 113: 410-412, 1975

    Google Scholar 

  115. Alessi D: Lesioni parenchimatose del cervelleto da carcinoma uterino (gliossi carcinotossica?). Riv Pathol Nerv Ment 55: 148-174, 1940

    Google Scholar 

  116. Bakheit AMO, Kennedy PGE, Behan PO: Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psych 12: 1084-1088, 1990

    Google Scholar 

  117. Bateman DE, Weller RO, Kennedy P: Stiffman syndrome: a rare paraneoplastic disorder. J Neurol Neurosurg Psych 53: 695-696, 1990

    Google Scholar 

  118. Batson OA, Fantle DM, Stewart JA: Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone. Cancer 69: 1291-1293, 1992

    PubMed  Google Scholar 

  119. Bellur SN: Opsoclonus: its clinical value. Neurol 25: 502-507, 1975

    Google Scholar 

  120. Beresford OD, McLetchie NGB: Hodgkin's disease: an unusual case with spinal symptoms. British Med J 2: 136-137, 1948

    Google Scholar 

  121. Boghen D, Sebag M, Michaud J: Paraneoplastic optic neuritis and encephalomyelitis. Ann Neurol 45: 353-358, 1988

    Google Scholar 

  122. Brain L, Wilkinson M: Subacute cerebellar degeneration associated with neoplasms. Brain 88: 465-478, 1965

    PubMed  Google Scholar 

  123. Brashear HR, Li L, Herr JC: Antineuronal antibody in two patients with paraneoplastic opsoclonus-ataxia. Neurol 42(suppl 3): 457, 1992

    Google Scholar 

  124. Bray PF, Ziter FA, Lahey E, Meyers GG: The coincidence of neuroblastoma and acute cerebellar encephalopathy. J Pediatrics 75: 983-990, 1969

    Google Scholar 

  125. Brazis PW, Biller J, Fine M, Palacios E, Pagano RJ: Cerebellar degeneration with Hodgkin's disease. Computed tomography correlation and literature review. Arch Neurol 38: 253-256, 1981

    PubMed  Google Scholar 

  126. Buchanan DS, Malamud N: Motor neuron disease with renal cell carcinoma and postoperative neurologic remission. Neurol 23: 891-894, 1973

    Google Scholar 

  127. Buchanan TAS, Gardiner TA, Archer DB: An ultrasound study of retinal photoreceptor degeneration associated with bronchial carcinoma. Amer J Ophthalmol 97: 277-287, 1984

    Google Scholar 

  128. Burton GV, Bullard DE, Walther PJ, Burger PC: Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 62: 2248-2251, 1988

    PubMed  Google Scholar 

  129. Carr-Locke DL: Autonomic neuropathy and inappropriate secretion of antidiuretic hormone. J American Med Ass 241: 2298, 1979

    Google Scholar 

  130. Case Records of the Massachusetts General Hospital 46421. New England J Medicine 263: 804-808, 1960

    Google Scholar 

  131. Chalk CH, Widebank AJ, Kimmel DW, McManis PG: The distinctive clinical features of paraneoplastic sensory neuronopathy. Canadian J Neurol Sci 19: 346-351, 1992

    Google Scholar 

  132. Chiappa KH, Young RR: A case of paracarcinomatous pandysautonomia. Neurol 23: 423, 1973

    Google Scholar 

  133. Corsellis JAN, Goldberg GJ, Norton AR: 'Limbic encephalitis' and its association with carcinoma. Brain 91: 481-496, 1968

    PubMed  Google Scholar 

  134. Croft PB, Henson RA, Urich H, Wilkinson PC: Sensory neuropathy with bronchial carcinoma: a study of four cases showing serological abnormalities. Brain 88: 501-514, 1965

    PubMed  Google Scholar 

  135. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB: Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurol 41: 1757-1764, 1991

    Google Scholar 

  136. Dansey RD, Hammond-Tooke GD, Lai K, Bezwoda WR: Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's disease. Med Ped Oncol 16: 284-286, 1988

    Google Scholar 

  137. Darnell RB, DeAngelis LM: Regression of small cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341: 21-22, 1993

    PubMed  Google Scholar 

  138. Digre KB: Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol 43: 1165-1175, 1986

    PubMed  Google Scholar 

  139. Dorfman LJ, Forno LS: Paraneoplastic encephalomyelitis. Acta Neurologica Scandinavica 48: 556-574, 1972

    PubMed  Google Scholar 

  140. Downie AW: Subacute cerebellar atrophy following carcinoma of the ovaries. Proc Royal Soc Medicine 48: 181, 195

  141. Dropcho EJ, Kline LB, Riser J: Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Neurol 43: 207-211, 1993

    Google Scholar 

  142. Dyck PJ, Bailey AA, Olszewski J: Carcinomatous neuromyopathy: a case of sensory neuropathy and myopathy with onset three and one-half years before clinical recognition of the bronchogenic carcinoma. Canadian Med Ass J 79: 913-916, 1958

    Google Scholar 

  143. Ellenberger C, Netsky MG: Anatomic basis and diagnostic value of opsoclonus. Arch Ophthalm 83: 307-310, 1970

    Google Scholar 

  144. Furneaux HM, Reich L, Posner JB: Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurol 40: 1085-1091, 1990

    PubMed  Google Scholar 

  145. Gennaula CP, Eidelman BH: Anti-Ri paraneoplastic syndrome in association with primary lung carcinoma. Neurol 451: 1417, 1995

    Google Scholar 

  146. Gerling GM, Woolsey RM: Paraneoplastic motor neurone disease. Mo Med 64: 503-506, 1967

    PubMed  Google Scholar 

  147. Graus F, Cordon-Cardo C, Cho ES, Posner JB: Opsoclonus and oat cell carcinoma of the lung: lack of evidence for anti-CNS antibodies. Lancet 1: 1479, 1984

    Google Scholar 

  148. Graus F, Cordon-Cardo C, Posner JB: Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurol 35: 538-543, 1985

    Google Scholar 

  149. Graus F, Elkon K, Cordon-Cardo C, Posner JB: Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Amer J Med 80: 45-52, 1986

    Google Scholar 

  150. Graus F, Abos J, Roquer J, Mazzara R, Pereira A: Effect of plamapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes. Neurol 40: 1621-1623, 1990

    Google Scholar 

  151. Greco FA, Kolins J, Rajjoub RK, Brereton HD: Hodgkin's disease and granulomatous angiitis of the central nervous system. Cancer 38: 2027-2032, 1976

    PubMed  Google Scholar 

  152. Greenlee JE, Brashear HR: Antibodies to cerebellar purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14: 609-613, 1983

    PubMed  Google Scholar 

  153. Greenlee JE, Brashear HR, Rodnitzsky RL, Corbett JJ, Digre KB: Fall in antineuronal antibody titers and improvement of neurologic deficits following tumor removal in paraneoplastic cerebellar degeneration. Neurol 36(suppl 1): 334, 1986

    Google Scholar 

  154. Grisold W, Lutz, Wolf D: Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of the literature. Acta Neuropath (Berl) 49: 231-235, 1983

    Google Scholar 

  155. Halperin JJ, Richardson EP, Ellis J, Ross JS, Ewing SH: Paraneoplastic encephalomyelitis and neuropathy. Arch Neurol 36: 773-775, 1981

    Google Scholar 

  156. Hammack JE, Kotanides H, Rosenblum MK, Posner JB: Paraneoplastic cerebellar degeneration. II clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurol 42: 1938-1943, 1992

    Google Scholar 

  157. Hawley RJ, Cohen MH, Saini N, ArmbrustmacherVW: The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol 7: 65-72, 1980

    PubMed  Google Scholar 

  158. Heathfield KWG, Turner JWA: Peripheral neuritis and carcinoma of bronchus. Proc Royal Soc Med 42: 229-30, 1982

    Google Scholar 

  159. Henson RA, Hoffman HL, Urich H: Encephalomyelitis with carcinoma. Brain 88: 449-464, 1965

    PubMed  Google Scholar 

  160. Hersh B, Dalmau J, Dangond F, Gultekin S, Geller E, Wen PY: Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurol 44: 1754-1755, 1994

    Google Scholar 

  161. Holmes A, Kilpatrick C, Proietto J, Green MD: Reversal of a neurologic paraneoplastic syndrome with octreotide (sandostatin) in a patient with glucagonoma. Amer J Med 91: 434-436, 1991

    PubMed  Google Scholar 

  162. Horwich L, Buxton PH, Ryan GMS: Cerebellar degeneration with Hodgkin's disease. J Neurol Neuro Psych 29: 45-51, 1966

    Google Scholar 

  163. Hughes M, Ahern V, Kefford R, Boyages J: Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease. Cancer 70: 1598-1600, 1992

    PubMed  Google Scholar 

  164. Ivy HK: Renal sodium loss and bronchogenic carcinoma. Arch Inter Med 108: 115-123, 1961

    Google Scholar 

  165. Kornguth SE, Klein R, Appen R, Choate J: Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 50: 1289-1913, 1982

    PubMed  Google Scholar 

  166. Lang B, Newsom-Davis J, Wray D, Vincent A: Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 2: 224-226, 1981

    PubMed  Google Scholar 

  167. Lechi A, Tedeschi F, TerzanoMG, Trabattoni G: Opsoclonus and myoclonus in malignant disease. A case report. Acta Neurologica (Napoli) 5: 205-209, 1983

    PubMed  Google Scholar 

  168. Lester EP, Feld E, Kinzie JJ, Wollmann R: Necrotizing myelopathy complicating Hodgkin's disease. Arch Neurol 36: 583-585, 1979

    PubMed  Google Scholar 

  169. Malamud N, Hirano A: Atlas of neuropatholgy, 2nd ed., Berkeley-Los Angeles-London: Univ of California Press, 302-303, 1974

    Google Scholar 

  170. Mancall EL, Rosales RK: Necrotizing myelopathy associated with visceral cancer. Brain 87: 629-636, 1964

    Google Scholar 

  171. McCaughey WTE, Milar JHD: Nervous degeneration in malignant disease. Lancet 2: 365-366, 1955

    Google Scholar 

  172. McDonaldW: Cortical cerebellar degeneration with ovarian cancer. Neurol 11: 328-334, 1961

    Google Scholar 

  173. Mitchell DM, Olczak SA: Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma. Brit Med J 2: 176-177, 1979

    Google Scholar 

  174. Ogilvie H: Large intestine colic due to sympathetic deprivation. A new clinical syndrome. Brit Med J 2: 671-673, 1948

    Google Scholar 

  175. Oh SJ: The Eaton-Lambert syndrome. Arch Neurol 27: 91-94, 1972

    PubMed  Google Scholar 

  176. Ohnishi A, Ogawa M: Preferential loss of large lumbar primary sensory neurons in carcinomatous sensory neuropathy. Ann Neurol 20: 102-104, 1986

    PubMed  Google Scholar 

  177. Ojeda VJ: Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and review of the literature. Cancer 53: 1115-1123, 1984

    PubMed  Google Scholar 

  178. Peacock A, Dawkins K, Rushworth G: Motor neurone disease associated with bronchial carcinoma? Brit Med J 2: 499-500, 1979

    Google Scholar 

  179. Pillay N, Gilber JJ, Brown JD: Internuclear ophthalmoplegia and 'optic neuritis'. Paraneoplastic effects of bronchial carcinoma. Neurol 34: 788-791, 1984

    Google Scholar 

  180. Prinz RA, Porenti AJ, Dorsch TR et al. Glucagon producing islet cell tumors of the pancreas. Proc Inst Med Chic 32: 133, 1979

    Google Scholar 

  181. Recine U, Longhi C, Pelosio A, Massine R: An unusually severe subacute motor neuronopathy in Hodgkin's disease. Acta Haematologica 71: 135-138, 1984

    PubMed  Google Scholar 

  182. Renullo JFC, Pineada R, Gaulio AR: Cutaneous melanomaassociated retinopathy with retinal periphlebitis. Arch Ophthalmol 113: 854-855, 1995

    PubMed  Google Scholar 

  183. Ross AT, Zeman W: Opsoclonus, occult carcinoma, and chemical pathology in dentate nuclei. Arch Neurol 17: 546-551, 1967

    PubMed  Google Scholar 

  184. Rowland LP, Schneck SA: Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Diseases 16: 777-795, 1963

    Google Scholar 

  185. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WE: Blindness caused by photoreceptor degeneration as a remote effect of cancer. Amer J Ophthalmol 81: 606-613, 1976

    Google Scholar 

  186. Schlake HP, Husstedt IW, Grotemeyer KH, Pötter R: Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease. Report of three cases and review of the literature. Clin Neurol Neurosurg 91: 329-335, 1989

    PubMed  Google Scholar 

  187. Schuffler MD, Baird HW, Fleming CR, Bell CE, Bouldin TW, Malagelade JR, McGill DB, LeBauer SM, Abram M, Lowe J: Intestinal Pseudo-obstruction as the presenting manifestation of small cell carcinoma of the lung. Ann Inter Med 98: 129-134, 1983

    Google Scholar 

  188. Sieben GM, DeReuck J, De Bruyne JC, Eecken HMV: Subacute necrotic myelopathy. Its appearance eight years after cure of breast cancer. Arch Neurol 38: 775-777, 1981

    PubMed  Google Scholar 

  189. Siemsen JK, Meister L: Bronchogenic carcinoma associated with severe orthostatic hypotension. Ann Inter Med 58: 669-676, 1963

    Google Scholar 

  190. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry ML: Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Digest Dis Sci 34: 1937-1942, 1989

    PubMed  Google Scholar 

  191. Steven MM, Mackay IR, Carnegie PR, Bhathal PS, Anderson R: Cerebellar cortical degeneration with ovarian carcinoma. Postgrad Med J 58: 47-51, 1982

    PubMed  Google Scholar 

  192. Tandon R, Walden M, Falcon S: Catatonia as a manifestation of paraneoplastic encephalopathy. J Clin Psych 49: 121-122, 1988

    Google Scholar 

  193. Telander RL, Smithson WA, Grover RV: Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Ped Surg 24: 11-14, 1989

    Google Scholar 

  194. Thirkill CE, Roth AM, Keltner JL: Cancer-associated retinopathy. Arch Ophthalmol 105: 372-375, 1987

    PubMed  Google Scholar 

  195. Thirkill GE, Fitzgerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL: Cancer associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells. New Engl J Med 321: 1589-1594, 1989

    PubMed  Google Scholar 

  196. Thomas JP, Shields R. Associated autonomic dysfunction and carcinoma of the pancreas. Brit Med J 4: 32, 1970

    PubMed  Google Scholar 

  197. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease: an immunological study. Arch Neurol 33: 660-661, 1976

    PubMed  Google Scholar 

  198. Tsapatsaris N, Wanger SL, Steinberg D: Cerebellar degeneration with Hodgkin's disease. Arch Inter Med 139: 829-830, 1979

    Google Scholar 

  199. Tsukamoto T, Mochizuki R, Mochizuki H, Noguchi M, Kayama H, Hiwatashi M, Yamamoto T: Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon. J Neurol Neurosurg Psych 56: 713-716, 1993

    Google Scholar 

  200. Turner JWA: Peripheral neuritis and carcinoma of the bronchus. Proc Royal Soc Med 45: 229, 1952

    Google Scholar 

  201. Valbonesi M, Montari F, Masconi L: A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathy. Haematologica 18: 33-43, 1985

    Google Scholar 

  202. Valldeoriole F, Vega F, Rene R, Pou A, Roquer J, Delattre JY, Graus F: Neurologic syndromes associated with anti Hu antibody. Study of 24 patients. Medicina Clinica 99: 361-410, 1992

    PubMed  Google Scholar 

  203. Valtysson G, Fisher-Beckfield P, Carbone PP: Cerebellar degeneration with Hodgkin's disease. Canc J Clin 29: 246-249, 1979

    Google Scholar 

  204. Vick N, Schulman S, Dau P: Carcinomatous cerebellar degeneration, encephalomyelitis and sensory neuropathy (radiculits). Neurol 19: 425-444, 1969

    Google Scholar 

  205. Walton JN, Tomlinson BE, Pearce GW: Subacute 'poliomyelitis' and Hodgkin's disease. J Neurol Sci 6: 435-445, 1968

    PubMed  Google Scholar 

  206. Waterhouse DM, Natale RB, Cody RL: Breast cancer and paraneoplastic cerebellar degeneration. Cancer 68: 1835-1841, 1991

    PubMed  Google Scholar 

  207. Waterston JA, Gilligan BS: Paraneoplastic optic neuritis and external ophthalmoplegia. Austral New Zealand J Med 16: 703-704, 1986

    Google Scholar 

  208. Weissman DE, Gottschall JL: Complete remission of paraneoplastic sensorimotor neuropathy: a case associated with small cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy. J Clin Apher 5: 3-6, 1989

    Google Scholar 

  209. Wessel K, Diener HC, Schroth G, Dichgan J: Paraneoplastic cerebellar degeneration associated with Hodgkin's disease. J Neurol 235: 122-124, 1987

    PubMed  Google Scholar 

  210. Wiley RG, Anderson NE, Hollister A, Posner J: Autonomic insufficiency in the paraneoplastic neuropathy of oat cell carcinoma. Neurol 38(suppl 1): 115, 1988

    Google Scholar 

  211. Wurzer H, Brandstätter G, Harnoncourt K, Kullnig P, Kleinert R: Paraneoplastic polymyositis associated with a renal carcinoma. J Inter Med 234: 521-524, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Instructor National University of Singapore, Senior Registrar Singapore General Hospital, Singapore

    Asha Das

  2. Boston, MA, USA

    Fred H. Hochberg (Associate Professor Harvard Medical School, Attending Neurologist Massachusetts General Hospital)

  3. Boston, MA, USA

    Sean McNelis (Research Associate Massachusetts General Hospital)

Authors
  1. Asha Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fred H. Hochberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sean McNelis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Das, A., Hochberg, F.H. & McNelis, S. A Review of the Therapy of Paraneoplastic Neurologic Syndromes. J Neurooncol 41, 181–194 (1999). https://doi.org/10.1023/A:1006133102928

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006133102928

Search

Navigation